Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-007483
Filing Date
2025-03-03
Accepted
2025-03-03 16:08:20
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4620
  Complete submission text file 0001127602-25-007483.txt   6381
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 SOMERSET CORPORATE BLVD BRIDGEWATER NJ 08807
Business Address
Barresi John S (Reporting) CIK: 0001578223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 25697884